A Study of an Oral Nutritional Supplement in a Malnourished Population With GI Tolerance Impairment

CompletedOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

November 28, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Malnutrition
Interventions
OTHER

Nutritional Supplement

High calorie, high protein peptide based

Trial Locations (23)

11407

Hospital de Jerez, Cadiz

14004

Hospital Universitario Reina Sofía de Córdoba, Córdoba

18016

Hospital Universitario Campus de la Salud, Granada

24080

Complejo Asistencial Universitario de Leon, Endocrinologia y Nutricion, León

24404

Hospital del Bierzo, Ponferrada

28034

Hospital Ramón y Cajal, Madrid

28046

Hospital Universitario La Paz, Madrid

28805

Hospital Universitario Principe de Asturias, Madrid

28933

Hospital Rey Juan Carlos, Móstoles

28935

Hospital Universitario de Móstoles, Madrid

29007

Centro Médico San Juan de la Cruz, Málaga

29603

Hospital Costa del Sol 1740, Marbella

Hospital Costa del Sol 1743, Marbella

30003

Hospital General Universitario Reina Sofía de Murcia, Murcia

41013

Hospital Universitario Virgen del Rocío, Seville

46010

Hospital Clínico Universitario de Valencia 1695, Valencia

46600

Hospital La Ribera, Valencia

48903

Hospital de Cruces 1758, Barakaldo

Hospital de Cruces 2029, Barakaldo

50009

Hospital Universitario Miguel Servet, Zaragoza

08916

Hospital Universitario Germans Trias i Pujol, Badalona

03314

Hospital Vega Baja, Orihuela

08500

Hospital de Vic, Vic

All Listed Sponsors
lead

Abbott Nutrition

INDUSTRY

NCT02698540 - A Study of an Oral Nutritional Supplement in a Malnourished Population With GI Tolerance Impairment | Biotech Hunter | Biotech Hunter